Marc Van Den Bulcke
Overview
Explore the profile of Marc Van Den Bulcke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
314
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Volders P, Aftimos P, Dedeurwaerdere F, Martens G, Canon J, Beniuga G, et al.
NPJ Precis Oncol
. 2025 Mar;
9(1):66.
PMID: 40065106
The Belgian Approach for Local Laboratory Extensive Tumor Testing (BALLETT) study assessed the feasibility of using comprehensive genomic profiling (CGP) in clinical decision-making for patients with advanced cancers. This multi-center...
2.
Schmitt T, Delnord M, Cauet E, Van Valckenborgh E, Van Den Bulcke M
J Health Organ Manag
. 2025 Mar;
PMID: 40045482
Purpose: Precision medicine, also known as personalized medicine, enables the provision of tailored health services to patients. In the prevention, early detection, and treatment of cancers, precision medicine is highly...
3.
Horgan D, Tanner M, Aggarwal C, Thomas D, Grover S, Basel-Salmon L, et al.
JCO Glob Oncol
. 2025 Jan;
11():e2400416.
PMID: 39847746
Despite the acknowledged merits of precision oncology (PO) and its increasing global implementation, its full potential for advancing care and prevention remains unrealized. The benefits are currently accessible to only...
4.
Horgan D, Hofman P, Giacomini P, Dube F, Singh J, Schneider D, et al.
Diagnosis (Berl)
. 2024 Dec;
PMID: 39686656
Personalized medicine, aiming to tailor treatments based on individual patient characteristics, holds immense potential in oncology. However, its widespread adoption in Europe faces numerous challenges, as illustrated by the case...
5.
Horgan D, Van Den Bulcke M, Malats N, De Maria R, Dube F, Singh J, et al.
Healthcare (Basel)
. 2024 Dec;
12(23).
PMID: 39684960
Background: A comparison of the operations of Clinical Cancer Centers and Comprehensive Cancer Centers across Europe provides novel data on the interrelation between different factors in care delivery. Method: The...
6.
Stellacci E, Martinelli S, Carbone P, Demuru E, Genuardi M, Ghiorzo P, et al.
Front Med (Lausanne)
. 2024 Dec;
11:1422163.
PMID: 39640978
Background: Genetic and genomic literacy of health professionals is of utmost importance to realize the full potential of personalized medicine. As part of a European Union project, we piloted an...
7.
Delnord M, Schittecatte G, Ghattas J, Van Den Bulcke M
Arch Public Health
. 2024 Sep;
82(Suppl 1):164.
PMID: 39327629
Cancer is one of the main public health challenges globally. In Europe, it is also the second leading cause of mortality and incidence is likely to increase from nearly 4...
8.
Cauet E, Schittecatte G, Van Den Bulcke M
Arch Public Health
. 2024 Aug;
82(Suppl 1):142.
PMID: 39198864
Artificial Intelligence (AI) is already a reality in health systems, bringing benefits to patients, healthcare providers, and other stakeholders in the health care. To further leverage AI in health, Belgium...
9.
Toungouz G, Poirel H, Schittecatte G, Van Den Bulcke M
Arch Public Health
. 2024 Aug;
82(Suppl 1):134.
PMID: 39187874
Research is central to achieving Europe's Beating Cancer Plan, and is the key focus of the European Commission's Mission on Cancer. To successfully tackle the challenges we face in cancer...
10.
McCrary J, Van Valckenborgh E, Poirel H, de Putter R, van Rooij J, Horgan D, et al.
Eur J Public Health
. 2024 Jun;
34(4):666-675.
PMID: 38905592
Background: Somatic and germline genetic alterations are significant drivers of cancer. Increasing integration of new technologies which profile these alterations requires timely, equitable and high-quality genetic counselling to facilitate accurate...